Vanessa Tassell
About Vanessa Tassell
Vanessa Tassell serves as the Vice President of Clinical Science at Mirati Therapeutics, a position she has held since 2018. She has extensive experience in the pharmaceutical industry, having worked in various roles at Pfizer and Mirati Therapeutics over the course of her career.
Current Role at Mirati Therapeutics
Vanessa Tassell serves as the Vice President of Clinical Science at Mirati Therapeutics. She has held this position since 2018, contributing to the company's focus on innovative therapies for cancer treatment. Her role involves overseeing clinical development strategies and ensuring the successful execution of clinical trials. Based in San Diego, California, she plays a critical part in advancing the company's research initiatives.
Previous Experience at Mirati Therapeutics
Prior to her current role, Vanessa Tassell worked at Mirati Therapeutics as the Executive Director of Clinical Science from 2016 to 2018. She also served as the Senior Director of Clinical Science from 2013 to 2016. During her tenure, she was involved in various clinical projects that aimed to enhance the company's oncology portfolio.
Experience at Pfizer
Vanessa Tassell has extensive experience at Pfizer, where she held multiple positions from 2000 to 2013. She worked as a Regional Monitor Manager in Oncology, followed by roles as Program Manager, Director of Clinical Oncology, and Associate Director. Her time at Pfizer spanned over a decade and involved significant contributions to clinical research and development in oncology.
Education and Qualifications
Vanessa Tassell earned a Bachelor of Science degree from Northeastern University, where she studied from 1988 to 1993. This educational background provided her with a solid foundation in the sciences, which has been instrumental in her career in clinical research and development.
Early Career at Parexel
Vanessa Tassell began her career at Parexel, where she worked as a Senior Clinical Research Associate and Line Manager from 1996 to 2000. This role allowed her to gain valuable experience in clinical trial management and research, setting the stage for her future positions in the pharmaceutical industry.